Stocks
Lexeo Therapeutics, Inc.LXEO
NASDAQHealthcareBiotechnology$3.00
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing gene therapies for rare diseases of the central nervous system. Its lead programs target inherited retinal and neurodegenerative conditions, with a focus on adeno-associated virus (AAV) based delivery. Investors track LXEO for its pipeline progress and potential in the gene therapy space.
52W Range: $2.55-$10.99
Congressional Interest in Lexeo Therapeutics, Inc. (LXEO)
No congressional trades have been disclosed for Lexeo Therapeutics, Inc. (LXEO) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading LXEO?
No congressional trades found for this stock.